Extina Related Published Studies
Well-designed clinical trials related to Extina (Ketoconazole Topical)
Efficacious and safe management of moderate to severe scalp seborrhoeic dermatitis using clobetasol propionate shampoo 0.05% combined with ketoconazole shampoo 2%: a randomized, controlled study. [2011.07]
Synergistic effects of tetrandrine on the antifungal activity of topical
ketoconazole cream in the treatment of dermatophytoses: a clinical trial. [2011]
Comparative evaluation of ketoconazole tablet and topical ketoconazole 2% in orabase in treatment of Candida-infected denture stomatitis. [2010.03.01]
An open, randomized, prospective, comparative study of topical pimecrolimus 1% cream and topical ketoconazole 2% cream in the treatment of seborrheic dermatitis. [2009]
Comparative efficacy and tolerability of Ketomousse (ketoconazole foam 1%) and ketoconazole cream 2% in the treatment of pityriasis versicolor: results of a prospective, multicentre, randomised study. [2008.11]
A novel foam formulation of ketoconazole 2% for the treatment of seborrheic dermatitis on multiple body regions. [2007.10]
Comparison between fluconazole and ketoconazole effectivity in the treatment of pityriasis versicolor. [2007.07]
Metronidazole 0.75% gel vs. ketoconazole 2% cream in the treatment of facial seborrheic dermatitis: a randomized, double-blind study. [2007.03]
Well-designed clinical trials possibly related to Extina (Ketoconazole Topical)
Exploratory study on the clinical and mycological effectiveness of a herbal medicinal product from Solanum chrysotrichum in patients with Candida yeast-associated vaginal infection. [2009.04]
Combination of surgical avulsion and topical therapy for single nail onychomycosis: a randomized controlled trial. [2007.08]
Other research related to Extina (Ketoconazole Topical)
Synergistic effects of tetrandrine on the antifungal activity of topical ketoconazole cream in the treatment of dermatophytoses: a clinical trial. [2011.07]
Investigating effect of microemulsion components: In vitro permeation of ketoconazole. [2011.06]
Comparative evaluation of ketoconazole tablet and topical ketoconazole 2% in
orabase in treatment of Candida-infected denture stomatitis. [2010]
Ocular pharmacokinetics of topically-applied ketoconazole solution containing hydroxypropyl beta-cyclodextrin to rabbits. [2008.10]
Ketoconazole: a review of a workhorse antifungal molecule with a focus on new foam and gel formulations. [2008.05]
Reduction of fluconazole susceptibility of Candida albicans in APECED patients due to long-term use of ketoconazole and miconazole. [2008]
Effect of coadministered ketoconazole, a strong cytochrome P450 3A4 enzyme inhibitor, on the pharmacokinetics of ciclesonide and its active metabolite desisobutyryl-ciclesonide. [2008]
The role of ketoconazole in seborrheic dermatitis. [2007.10]
Ketoconazole gel 2% in the treatment of moderate to severe seborrheic dermatitis. [2007.06]
A new ketoconazole topical gel formulation in seborrhoeic dermatitis: an updated review of the mechanism. [2007.06]
In vitro activity of an ear rinse containing tromethamine, EDTA, benzyl alcohol and 0.1% ketoconazole on Malassezia organisms from dogs with otitis externa. [2007.04]
Comparison of different perrmeation enhancers on topical ketoconazole formulations. [2007]
Other possibly related research studies
Fusarium keratitis in Mexico. [2009.07]
Interventions for American cutaneous and mucocutaneous leishmaniasis. [2009.04.15]
Case of cutaneous Scedosporium apiospermum infection successfully treated with voriconazole. [2009.02]
Pathogenesis and outcome of Paecilomyces keratitis. [2009.04]
Evidence-based veterinary dermatology: a systematic review of interventions for Malassezia dermatitis in dogs. [2009.02]
Arthroderma vanbreuseghemii infection in three family members with kerion and tinea corporis. [2008.12.29]
Development of effective ocular preparations of antifungal agents. [2008.10]
Management of Malassezia-related diseases in the dog. [2008.06]
Evaluation and treatment of oral candidiasis in HIV/AIDS patients in Enugu, Nigeria. [2008.07]
Seborrheic dermatitis flare in a Dutch male due to commensal Malassezia furfur overgrowth. [2008.09]
The significance of itraconazole for treatment of fungal infections of skin, nails and mucous membranes. [2009.01]
Refractory hypercalcemia in an infant secondary to talc pleurodesis resolving after renal transplantation. [2008.06]
Voriconazole for the treatment of refractory Aspergillus fumigatus keratitis. [2008.05]
Bilateral tinea nigra in a temperate climate. [2007.07.13]
[Malassezia folliculitis: characteristics and therapeutic response in 26 patients] [2007.11]
[Treatment of fungal infections of upper respiratory tract and ear] [2007]
Tinea capitis: no incision nor excision. [2007.08]
Posaconazole for the management of mucosal candidiasis. [2007.06]
[Lithium gluconate 8% in the treatment of seborrheic dermatitis] [2007.04]
[Acanthamoeba keratitis: about the first two Tunisian cases] [2007.02]
Characterization of hot-melt extruded drug delivery systems for onychomycosis. [2007.04]
Rhabdomyomatous mesenchymal hamartoma: clinical overview and report of a case with spontaneous regression. [2009.12]
Therapeutic efficacy of topical OLEOZON in patients suffering from onychomycosis. [2010.05.17]
Cutaneous malasseziasis: four case reports of atypical dermatitis and onychomycosis caused by Malassezia. [2010.02]
Current concepts in systemic and topical therapy for superficial mycoses. [2010.03.04]
Use of antifungal agents for oral candidiasis: results of a national survey. [2010.02]
A case of cutaneous protothecosis successfully treated with local thermal therapy as an adjunct to itraconazole therapy in an immunocompromised host. [2010.06]
Beauveria keratitis and biopesticides: case histories and a random amplification of polymorphic DNA comparison. [2010.02]
[Guidelines for diagnosis and treatment of mucocutaneous candidiasis] [2009]
Dermatomycosis in a pet inland bearded dragon (Pogona vitticeps) caused by a Chrysosporium species related to Nannizziopsis vriesii. [2009.08]
Infectious keratitis caused by Aspergillus tubingensis. [2009.09]
Two cases of scalp white piedra caused by Trichosporon ovoides. [2009.05]
Arthroderma vanbreuseghemii infection in three family members with kerion and tinea corporis. [2009]
Topical antifungal agents for seborrheic dermatitis: systematic review and meta-analysis. [2011.06]
[A 25-year-old patient with corneal infiltration]. [2011.05]
The effects of intrastromal voriconazole injection and topical voriconazole in the treatment of recalcitrant Fusarium keratitis. [2011.08]
Severe retention hyperkeratosis occurring with Susac syndrome. [2010.10.15]
Topical delivery of antifungal agents. [2010.11]
Colletotrichum graminicola keratitis: first case report from India. [2010.09]
A case of kerion celsi caused by Microsporum gypseum in a boy following dermatoplasty for a scalp wound from a road accident. [2011.01]
Otomycosis due to Aspergillus spp. in a dog: case report and literature review. [2010.12]
Therapeutic efficacy of topical OLEOZON(R) in patients suffering from onychomycosis. [2011.09]
[Guidelines for diagnosis and treatment of mucocutaneous candidiasis]. [2009]
Oral treatments for fungal infections of the skin of the foot. [2012]
Roles of adapalene in the treatment of pityriasis versicolor. [2012]
Topical antifungal agents for seborrheic dermatitis: systematic review and
meta-analysis. [2011]
|
